EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Catalytic Protein Inhibitors

Thomas Kodadek iD

Angewandte Chemie International Edition · 11.03.2024 · 63 (11)

DOI: 10.1002/anie.202316726 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 12.01.2024. Verfasst von Thomas Kodadek. Beteiligte Einrichtung: Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 120 Scripps Way, Jupiter, FL 33458, USA. Hauptthemen laut MEDLINE: Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Center for Strategic Scientific Initiatives, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many of the highest priority targets in a wide range of disease states are difficult‐to‐drug proteins. The development of reversible small molecule inhibitors for the active sites of these proteins with sufficient affinity and residence time on‐target is an enormous challenge. This has engendered interest in strategies to increase the potency of a given protein inhibitor by routes other than further improvement in gross affinity. Amongst these, the development of catalytic protein inhibitors has garnered the most attention and investment, particularly with respect to protein degraders, which catalyze the destruction of the target protein. This article discusses the genesis of the burgeoning field of catalytic inhibitors, the current state of the art, and exciting future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinsCatalysisCatalytic DomainProteolysis

Stichwörter der Autor:innen

CatalysisInhibitorMolecular GluePROTACPhoto-Oxidation

Substanzen

Proteins

Autor:innen und Institutionen

  • Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 120 Scripps Way, Jupiter, FL 33458, USA.

ORCID-Profile: Thomas Kodadek

Förderung

  • NCI NIH HHS
  • Center for Strategic Scientific Initiatives, National Cancer Institute

Zitieren

APA

Kodadek, T. (2024). Catalytic Protein Inhibitors. Angewandte Chemie International Edition, 63(11). https://doi.org/10.1002/anie.202316726

Vancouver

Kodadek T. Catalytic Protein Inhibitors. Angewandte Chemie International Edition. 2024;63(11). doi:10.1002/anie.202316726

BibTeX
@article{Kodadek2024,
  author = {Kodadek, Thomas},
  title = {Catalytic Protein Inhibitors},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {11},
  doi = {10.1002/anie.202316726}
}
Kostenlos starten →